1. Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes
   Elisa Bientinesi et al, 2022, Mechanisms of Ageing and Development CrossRef
2. From Spheroids to Bioprinting: A Literature Review on Biomanufacturing Strategies of 3D In Vitro Osteosarcoma Models
   Margarida F. Domingues et al, 2024, Advanced Therapeutics CrossRef
3. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease
   Jingnan Chen et al, 2021, Biomedicine & Pharmacotherapy CrossRef
4. Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway
   Tong Guo et al, 2023, Frontiers in Oncology CrossRef
5. Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review)
   Tian Xia et al, 2024, Biomedical Reports CrossRef
6. Ampelopsin Inhibits Breast Cancer Cell Growth through Mitochondrial Apoptosis Pathway
   Yue Li et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
7. Ampelopsin targets in cellular processes of cancer: Recent trends and advances
   Hardeep Singh Tuli et al, 2022, Toxicology Reports CrossRef
8. Association of interleukin 16 gene polymorphisms and plasma IL16 level with osteosarcoma risk
   Yu-Jin Tang et al, 2016, Scientific Reports CrossRef
9. Knockdown of Kinesin Family 15 Inhibits Osteosarcoma through Suppressing Cell Proliferation and Promoting Cell Apoptosis
   Zhiqiang Wu et al, 2019, Chemotherapy CrossRef
10. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
    Jiajun Wu et al, 2022, Cancers CrossRef
11. Investigating ego modules and pathways in osteosarcoma by integrating the EgoNet algorithm and pathway analysis
    X.Y. Chen et al, 2017, Brazilian Journal of Medical and Biological Research CrossRef